UK 06:11 Saturday, 24 October 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Thanks to kind reader A, I bring you a page from this week’s Private Eye where it appears to recognize the good work done by this website even if it cannot actually spell our name. Poor Uncle Chris, who co-founded the Eye, will yet again spin in his grave. The article concerns the woes of struck off dentist Ajan Rejinald which we have exposed on this website and which the Eye is now regurgitating. As is always the case, but especially with the Novacyt (NCYT) trial looming, anyone owning shares in Rejinald’s Roquefort (ROQ) needs their head examining.
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
